FDA clears Vasomedical's Holter monitors

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Vasomedical has received FDA market clearance for two new monitors: the Biox Model 1303 3-channel ECG Holter Monitor and Model 1304 12-channel ECG Holter Monitor.

The approval of the two new monitors completes a line of ambulatory monitoring products for long-term recording and analysis of ECG and blood pressure data, according to the company. Vasomedical added that its Biox monitors work with CB Series Analysis Software.

Vasomedical will showcase its Biox products at the upcoming Florida International Medical Expo in Miami Beach, Fla., from Aug. 11-12 and the European Society of Cardiology Congress in Paris, Aug. 27-30.